Artwork

Content provided by Salk Institute for Biological Studies. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Salk Institute for Biological Studies or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Reuben Shaw - Where Cures Begin – Episode 014

15:59
 
Share
 

Manage episode 264160004 series 1261285
Content provided by Salk Institute for Biological Studies. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Salk Institute for Biological Studies or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Reuben Shaw is a professor and the director of the Salk Cancer Center. Fifteen years ago, he discovered that a gene frequently mutated in cancer (LKB1) regulates an enzyme named AMPK. Ever since, he has been studying the AMPK pathway to see if drugs originally designed to treat metabolic diseases could also work against cancer. On this episode of Where Cures Begin, Shaw talks about his initial discovery; what it’s like running the Salk Cancer Center; and his continual drive to study the hardest-to-treat cancers.

  continue reading

32 episodes

Artwork
iconShare
 
Manage episode 264160004 series 1261285
Content provided by Salk Institute for Biological Studies. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Salk Institute for Biological Studies or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Reuben Shaw is a professor and the director of the Salk Cancer Center. Fifteen years ago, he discovered that a gene frequently mutated in cancer (LKB1) regulates an enzyme named AMPK. Ever since, he has been studying the AMPK pathway to see if drugs originally designed to treat metabolic diseases could also work against cancer. On this episode of Where Cures Begin, Shaw talks about his initial discovery; what it’s like running the Salk Cancer Center; and his continual drive to study the hardest-to-treat cancers.

  continue reading

32 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play